Literature DB >> 32461672

Kawasaki disease linked to COVID-19 in children.

Alvaro Moreira1.   

Abstract

Entities:  

Year:  2020        PMID: 32461672      PMCID: PMC7251555          DOI: 10.1038/s41577-020-0350-1

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
An unusually high incidence of Kawasaki disease in children was reported in a French centre for emerging infectious diseases: 17 cases in 11 days, in contrast to an average of 2 cases per month in 2018–2019. In 82% of the cases, IgG antibodies for SARS-CoV-2 were detected, suggesting an association between the virus and this syndrome in children. Although only six patients had recent history of an acute respiratory infection, all patients had gastrointestinal symptoms before the onset of Kawasaki disease symptoms. Remarkably, almost 60% of the patients originated from sub-Saharan Africa or Caribbean islands, and 12% from Asia, raising a possible genetic predisposition. Although Kawasaki disease-like syndromes have previously been linked to other viral infections, these patients showed higher levels of pro-inflammatory markers than other cohorts, which may reflect a particularly strong immunological reaction to SARS-CoV-2.
  8 in total

1.  The Blood Gene Expression Signature for Kawasaki Disease in Children Identified with Advanced Feature Selection Methods.

Authors:  Bing Hu; Yun Li; Guilian Wang; Yanqing Zhang
Journal:  Biomed Res Int       Date:  2020-06-28       Impact factor: 3.411

2.  Characteristics of Children With Kawasaki Disease-Like Signs in COVID-19 Pandemic: A Systematic Review.

Authors:  Parham Mardi; Marzieh Esmaeili; Parisa Iravani; Mohammad Esmail Abdar; Kumars Pourrostami; Mostafa Qorbani
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

3.  How Children Are Protected From COVID-19? A Historical, Clinical, and Pathophysiological Approach to Address COVID-19 Susceptibility.

Authors:  Magdalena Anna Massalska; Hans-Jürgen Gober
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

Review 4.  Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.

Authors:  Kazunari Kaneko; Shohei Akagawa; Yuko Akagawa; Takahisa Kimata; Shoji Tsuji
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

5.  Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection.

Authors:  Rosaria Talarico; Chiara Stagnaro; Francesco Ferro; Linda Carli; Marta Mosca
Journal:  Lancet Rheumatol       Date:  2020-07-13

6.  As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention.

Authors:  Craig R Travis
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

7.  Paediatric multisystem inflammatory syndrome associated with COVID-19: filling the gap between myocarditis and Kawasaki?

Authors:  Jeanne Bordet; Stéphanie Perrier; Catherine Olexa; Anne-Cécile Gerout; Philippe Billaud; Laurent Bonnemains
Journal:  Eur J Pediatr       Date:  2020-09-21       Impact factor: 3.183

Review 8.  How Common is Long COVID in Children and Adolescents?

Authors:  Petra Zimmermann; Laure F Pittet; Nigel Curtis
Journal:  Pediatr Infect Dis J       Date:  2021-12-01       Impact factor: 2.129

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.